Shandong Buchang Pharmaceuticals (603858.SH) plans to repurchase shares amounting to 50 million to 100 million yuan and has obtained a letter of commitment for a special loan for the repurchase.

Shandong Buchang Pharmaceuticals (603858.SH) disclosed a share repurchase plan. The company plans to repurchase shares with a total amount of funds of 50 million to 100 million yuan, with a repurchase price not exceeding 23 yuan per share. The repurchased shares will be used for equity incentives, employee stock ownership plans, and the conversion of convertible corporate bonds issued by listed companies. The source of funds for this repurchase will come from the company's own funds and specialized repurchase loans from financial institutions. Company's own funds will not be less than 10% of the total repurchase amount, while the specialized repurchase loans from financial institutions will not exceed 90% of the total repurchase amount. Recently, the company received a "Listed Company Stock Repurchase Loan Commitment Letter" from the Industrial and Commercial Bank of China Shandong Branch, pledging to provide the company with a renminbi loan of up to 500 million yuan, with a term not exceeding 3 years and an interest rate of 2%, specifically for the company's stock repurchase activities after the date of issuance of this commitment letter.